CASI Pharmaceuticals Inc (NASDAQ:CASI)

6.84
Delayed Data
As of Apr 18
 -0.09 / -1.30%
Today’s Change
0.91
Today|||52-Week Range
7.59
+110.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash10.7M5.1M27.1M43.5M
 
 
 
 
 
Short Term Investment Cash-4.5M-5.5M22.0M16.4M
 
 
 
 
 
Cash & Short Term Investments10.7M5.1M27.1M43.5M
 
 
 
 
 
 
ReceivablesReceivables23.7K0.000.000.00
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets328.2K438.2K355.9K322.5K
 
 
 
 
 
Current Assets11.0M5.6M27.4M43.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross486.9K512.3K491.6K1.4M
 
 
 
 
 
Depreciation-225.2K-293.5K-262.0K-372.3K
 
 
 
 
 
Other Assets26.0K38.2K34.5K242.0K
 
 
 
 
 
Total Assets11.3M5.8M27.7M45.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable491.6K884.1K1.1M2.1M
 
 
 
 
 
Accrued Expenses417.8K165.4K251.0K746.0K
 
 
 
 
 
Other Current Liabilities427.4K169.5K251.0K3.0M
 
 
 
 
 
Other Liabilities919.0K1.1M1.3M5.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt1.4M1.5M1.5M1.5M
 
 
 
 
 
Other Liabilities9.4M9.4M4.1M0.00
 
 
 
 
Total Liabilities11.7M11.9M6.9M6.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity-422.2K-6.1M20.8M38.5M
 
 
 
 
 
Total Shareholder Equity-422.2K-6.1M20.8M38.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding32.4M32.4M60.2M69.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.